INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹87 Cr | ₹73 Cr | ₹60 Cr | ₹47 Cr | ₹38 Cr |
What is the latest Total Current Assets ratio of INDO US BIOTECH ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹38 Cr |
How is Total Current Assets of INDO US BIOTECH Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 18.66 | |
| Mar2024 | ₹73 Cr | 22.00 | |
| Mar2023 | ₹60 Cr | 27.31 | |
| Mar2022 | ₹47 Cr | 23.40 | |
| Mar2021 | ₹38 Cr | - | |
Compare Total Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹209.4 Cr | 6.4% | -23.8% | -33.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,995.2 Cr | 8.5% | -8.6% | -18.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,460.3 Cr | 11% | 21.1% | -32.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,927.8 Cr | 16.8% | 8.6% | -16.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,177.2 Cr | 84.8% | 33.8% | -16.9% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹366.8 Cr | 0.3% | 12.7% | -25.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 6.4% |
-23.8% |
-33.4% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses